| Trial ID: | L6681 |
| Source ID: | NCT01201278
|
| Associated Drug: |
Insulin
|
| Title: |
PK/PD Study of Intranasal Insulin in Type I Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Insulin|DRUG: Insulin|DRUG: Insulin LISPRO
|
| Outcome Measures: |
Primary: Insulin tolerability, PK, and PD, To assess safety and tolerability, and to compare the insulin AUC over 0-120 min for each of the three insulin applications., 120 minutes |
|
| Sponsor/Collaborators: |
Sponsor: Hompesch, Marcus, M.D. | Collaborators: Profil Institute for Clinical Research, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-17
|
| Locations: |
Profil Institute for Clinical Research, Chula Vista, California, 91911, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01201278
|
